1. Bonadonna G, Valagussa P, Brambilla C, Ferrari L, Molinterni A, Terenziani M, Zambetti M (1998) Primary chemotherapy in operable breast cancer: eight years experience at the Milan Cancer Institute. J Clin Oncol 16: 93–100
2. Bottini A, Berruti A, Bersiga A, Brizzi MP, Allevi G, Bolsi G, Aguggini S, Brunelli A, Betri E, Generali D, Scaratti L, Bertoli G, Alquati P, Dogliotti L (2002) Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. Clin Cancer Res 8: 1816–1821
3. Bottini A, Berruti A, Bersiga A, Brizzi MP, Brunelli A, Gorzegno G, DiMarco B, Aguggini S, Bolsi G, Cirillo F, Filippini L, Betri E, Bertoli G, Alquati P, Dogliotti L (2000) p53 but not bcl2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. Clin Cancer Res 6: 2751–2758
4. Bottini A, Berruti A, Bersiga A, Brizzi MP, Bruzzi P, Aguggini S, Brunelli A, Bolsi G, Allevi G, Generali D, Betri E, Bertoli G, Alquati P, Dogliotti L (2001) Relationship between tumor shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer. Br J Cancer 85: 1106–1112
5. Canning MT, Postovit LM, Clarke SH, Graham CH (2001) Oxygen-mediated regulation of gelatinase and tissue inhibitor of metallo-proteinases-1 expression by invasive cells. Exp Cell Res 367: 88–94